Search for: "Application of Myers et al"
Results 61 - 80
of 84
Sort by Relevance
|
Sort by Date
20 Apr 2010, 6:09 am
Garfield & Johnson Enterprises, Inc., et al., 2010 U.S. [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
3 Mar 2010, 5:05 am
Assistance Publique - Hopitaux De Paris et al. [read post]
3 Mar 2010, 5:05 am
Assistance Publique - Hopitaux De Paris et al. [read post]
15 Feb 2010, 2:20 pm
Opinion below (6th Circuit) Petition for certiorari (09-533) Petition for certiorari (09-547) Brief in opposition (09-533/547) Brief in opposition for the federal respondent (09-533/547) Petitioners’ reply (09-533) Petitioners’ reply (09-547) Amicus brief of members of Congress (09-533/547) Amicus brief of American Mosquito Control Association et al. (09-533/547) Amicus brief of Aquatic Ecosystem Restoration Foundation… [read post]
7 Feb 2010, 11:28 pm
The case is Marc Jacobs Trademarks, LLC et al. v. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
28 Jun 2009, 6:17 pm
Hoffman-La Roche Inc., et al. [read post]
27 Feb 2009, 7:00 am
(Inventive Step) (Patent Docs) US Patents Applying Supreme Court precedent: Carlsbad Technology v HIF Bio (Patently-O) (Hal Wegner) USPTO not laying off employees (IP Watchdog) USPTO maintenance fees (Patently-O) Merchants warranty of non-infringement (Patently-O) PLI patent bar review tour (IP Watchdog) Provisional patent applications: waiting to file non-provisionals (Patently-O) 35 USC § 315(C) and its uncodified cousin – inter partes re-examination… [read post]
15 Dec 2008, 3:09 pm
Myers, et al., on Jan. 11 — five months before the Boumediene ruling came down. [read post]
26 Nov 2008, 7:17 pm
Myers, et al. [read post]
29 Sep 2008, 1:17 am
REFERENCES: JAMA articles (available for free download): Lang IA et al. [read post]
19 Sep 2008, 5:03 pm
Co., et al. [read post]
29 Aug 2008, 6:23 pm
.; et al. v. [read post]
23 Aug 2008, 1:23 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
16 Jul 2008, 6:00 pm
Alpharma, Inc., Caligor, Inc.; et al. , a 29-page, 2-1 decision, Judge Riley writes:The Kovachs raise one issue on appeal, which we restate as follows: Whether the trial court erred by entering summary judgment in favor of the Cup Defendants. [read post]
17 Jun 2008, 9:43 am
As Beaver, et al. well knew, these forces were already using cruel treatment in Afghanistan. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
9 Oct 2007, 8:25 pm
_, BILL McCOLLUM, etc., et al., Respondents. [read post]
